These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30445634)

  • 1. Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.
    Ollila ME; Kaikkonen K; Järvelin MR; Huikuri HV; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen L
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1221-1231. PubMed ID: 30445634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.
    West S; Vähäsarja M; Bloigu A; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Corbett S; Vääräsmäki M; Morin-Papunen L
    Hum Reprod; 2014 Mar; 29(3):628-33. PubMed ID: 24324025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Self-Reported Polycystic Ovary Syndrome, Obesity, and Weight Gain From Adolescence to Adulthood With Hypertensive Disorders of Pregnancy: A Community-Based Approach.
    Rantakallio JSS; Nevalainen JE; West SI; Ollila MM; Puukka K; Bloigu AH; Järvelin MR; Tapanainen JS; Franks S; Dunkel L; Piltonen TT; Vääräsmäki MS; Morin-Papunen LC
    Hypertension; 2021 Mar; 77(3):1010-1019. PubMed ID: 33517680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight, obesity and hyperandrogenemia are associated with gestational diabetes mellitus: A follow-up cohort study.
    West S; Ollila MM; Franks S; Piltonen T; Jokelainen J; Nevalainen J; Puukka K; Ruokonen A; Järvelin MR; Auvinen J; Tapanainen JS; Morin-Papunen L
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1311-1319. PubMed ID: 32333801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
    Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
    Koivunen R; Pouta A; Franks S; Martikainen H; Sovio U; Hartikainen AL; McCarthy MI; Ruokonen A; Bloigu A; Järvelin MR; Morin-Papunen L;
    Hum Reprod; 2008 Sep; 23(9):2134-9. PubMed ID: 18544581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of polycystic ovary syndrome on cardiac autonomic function at a late fertile age: a prospective Northern Finland Birth Cohort 1966 study.
    Ollila MM; Kiviniemi A; Stener-Victorin E; Tulppo M; Puukka K; Tapanainen J; Franks S; Morin-Papunen L; Piltonen T
    BMJ Open; 2019 Dec; 9(12):e033780. PubMed ID: 31843853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data.
    Kujanpää L; Arffman RK; Pesonen P; Hurskainen E; Järvelin MR; Franks S; Tapanainen JS; Morin-Papunen L; Piltonen TT
    Eur J Endocrinol; 2024 Jun; 190(6):409-420. PubMed ID: 38781435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study.
    Ollila MM; Piltonen T; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Morin-Papunen L
    J Clin Endocrinol Metab; 2016 Feb; 101(2):739-47. PubMed ID: 26652764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
    Taponen S; Martikainen H; Järvelin MR; Sovio U; Laitinen J; Pouta A; Hartikainen AL; McCarthy MI; Franks S; Paldanius M; Ruokonen A;
    J Clin Endocrinol Metab; 2004 May; 89(5):2114-8. PubMed ID: 15126528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome?
    Morin-Papunen LC; Duleba AJ; Bloigu A; Järvelin MR; Saikku P; Pouta A
    Fertil Steril; 2010 Oct; 94(5):1799-804. PubMed ID: 19931073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms.
    Karjula S; Morin-Papunen L; Franks S; Auvinen J; Järvelin MR; Tapanainen JS; Jokelainen J; Miettunen J; Piltonen TT
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1814-26. PubMed ID: 31970392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
    Joham AE; Boyle JA; Zoungas S; Teede HJ
    Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome.
    Joham AE; Kakoly NS; Teede HJ; Earnest A
    J Clin Endocrinol Metab; 2021 May; 106(6):1585-1593. PubMed ID: 33693653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.
    Karjula S; Morin-Papunen L; Auvinen J; Ruokonen A; Puukka K; Franks S; Järvelin MR; Tapanainen JS; Jokelainen J; Miettunen J; Piltonen TT
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1861-1869. PubMed ID: 28323926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity, arterial hypertension, metabolic disorders, and polycystic ovary syndrome].
    Quiñónez Zarza C; Silva Ruiz R; Torres Juárez JM
    Ginecol Obstet Mex; 2000 Jul; 68():317-22. PubMed ID: 11006648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
    Taponen S; Ahonkallio S; Martikainen H; Koivunen R; Ruokonen A; Sovio U; Hartikainen AL; Pouta A; Laitinen J; King V; Franks S; McCarthy MI; Järvelin MR
    Hum Reprod; 2004 May; 19(5):1083-8. PubMed ID: 15044401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome.
    Siddiqui IA; Tamimi W; Tamim H; Aleisa N; Adham M
    Arch Gynecol Obstet; 2010 Mar; 281(3):467-71. PubMed ID: 19462174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population-based cohort study.
    Kujanpää L; Arffman RK; Pesonen P; Korhonen E; Karjula S; Järvelin MR; Franks S; Tapanainen JS; Morin-Papunen L; Piltonen TT
    Acta Obstet Gynecol Scand; 2022 Jul; 101(7):728-736. PubMed ID: 35673942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.